BioMarin Pharmaceutical Inc. buy Cantor Fitzgerald
Start price
23.02.24
/
50%
€84.34
Target price
23.02.25
€92.36
Performance (%)
-13.14%
Price
05.06.24
€73.26
Summary
This prediction is currently active. The prediction for BioMarin Pharmaceutical Inc. disappoints with a performance of -13.14%. This prediction currently runs until 23.02.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
BioMarin Pharmaceutical Inc. | 5.440% | 5.440% |
iShares Core DAX® | 0.597% | 3.083% |
iShares Nasdaq 100 | 0.899% | 5.338% |
iShares Nikkei 225® | 1.775% | -1.206% |
iShares S&P 500 | 0.990% | 3.500% |
Comments by Cantor_Fitzgerald for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $100.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€76.58
25.04.24
25.04.24
€102.61
25.04.25
25.04.25
-4.34%
05.06.24
05.06.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€80.34
16.10.23
16.10.23
€113.65
16.10.24
16.10.24
-8.81%
05.06.24
05.06.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€85.26
13.09.23
13.09.23
€111.79
13.09.24
13.09.24
-14.07%
05.06.24
05.06.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€79.72
01.08.23
01.08.23
€109.34
01.08.24
01.08.24
-8.10%
05.06.24
05.06.24